[Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus]

Julián Torre-Cisneros1, Rocío Tejero García, Clara Natera Kindelán

  • 1Unidad Clínica de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, España.

Medicina Clinica
|October 29, 2011
PubMed
Abstract

Insights

Predicting methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial pneumonia (NP) is crucial for empiric therapy. A new model identifies key risk factors to guide antibiotic selection when MRSA is suspected.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Clinical Microbiology

Background:

  • Nosocomial pneumonia (NP) poses a significant challenge in healthcare settings.
  • Identifying the causative pathogen, particularly methicillin-resistant Staphylococcus aureus (MRSA), is vital for effective empiric antibiotic therapy.
  • Predictive models are needed to guide treatment decisions when microbiological data is unavailable.

Purpose of the Study:

  • To develop a predictive model for the probability of NP being caused by MRSA.
  • To identify risk factors associated with MRSA in nosocomial pneumonia.
  • To aid in the selection of appropriate empiric antibiotic coverage.

Main Methods:

  • Retrospective case-control study conducted from 1999 to 2005.
  • Univariate and multivariate logistic regression analysis to identify risk factors.
  • Inclusion of demographic, hospitalization-related, immunosuppression, medication, and severity factors.

Main Results:

  • A multivariate model identified age > 14 years, NP onset > 6 days post-admission, non-summer onset, presence of respiratory diseases, and multilobar involvement as significant predictors.
  • Odds ratios (OR) and confidence intervals (CI) were calculated for each risk factor.
  • A scoring system based on major and minor criteria was developed to estimate MRSA probability.

Conclusions:

  • Empiric MRSA coverage in NP is recommended for adult patients (>14 years) with at least 2 major criteria or 1 major and 2 minor criteria.
  • For pediatric patients (<14 years), 2 major and 2 minor criteria warrant MRSA coverage.
  • The model aids clinicians in optimizing empiric antibiotic strategies for NP.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...